Radiesse provides immediate correction when used for structural filling, while Sculptra develops correction gradually through a collagen response. For aesthetic providers comparing Radiesse vs Sculptra, the right choice depends on the treatment target, applicable product labeling, patient anatomy, and expected outcome.
Both products stimulate collagen, but they differ in composition, preparation, tissue behavior, FDA-approved indications, and treatment planning. This comparison focuses on U.S. indications and labeling, which may differ from approvals in other markets.
Radiesse vs Sculptra at a Glance
The clearest comparison starts with the material, intended outcome, preparation, and typical treatment approach.
| Factor | Radiesse / Radiesse (+) | Sculptra |
| Manufacturer | Merz Aesthetics | Galderma |
| Material | Calcium hydroxylapatite (CaHA) microspheres in a gel carrier | Poly-L-lactic acid (PLLA) microparticles |
| Presentation | Prefilled syringe | Freeze-dried powder in a vial |
| Early result | Immediate correction with structural use; diluted treatment has a different objective | Temporary fullness from fluid and swelling; lasting correction develops gradually |
| Preparation | Product and indication determine whether dilution is necessary | Requires reconstitution with sterile water for injection |
| Lidocaine | Radiesse (+) contains 0.3% lidocaine | May be added when permitted under applicable preparation instructions |
| Visit planning | Additional treatment may be appropriate; some indications use a treatment series | Typically involves staged treatment and reassessment between sessions |
How Radiesse Differs From Sculptra Clinically
Radiesse provides a gel carrier that can create immediate filling, while Sculptra relies primarily on a gradual tissue response for lasting correction.
Radiesse: Immediate Filling and a Later Collagen Response
Radiesse contains CaHA microspheres suspended in a gel carrier. The gel contributes to initial correction, while the tissue response surrounding the particles contributes to subsequent collagen formation.
Dilution changes how the product behaves. Adding fluid reduces the structural contribution of the gel and allows broader product distribution for treatment objectives that differ from structural filling.
Diluted or hyperdiluted Radiesse should therefore not be treated as interchangeable with standard structural Radiesse. FDA-approved dilution instructions are also indication-specific. For décolleté wrinkles, for example, the approved protocol uses Radiesse diluted 1:2 with 0.9% sterile saline.
This distinction is important when comparing Radiesse and Sculptra. Structural Radiesse, diluted Radiesse, and Sculptra can all be used in treatment plans involving collagen stimulation, but their preparation, clinical objectives, and applicable labeling differ.
Sculptra: Correction That Develops Over Time
Sculptra contains PLLA particles that stimulate a tissue response and collagen production over time. The fullness visible immediately after treatment does not represent the final result because reconstitution fluid and post-treatment swelling contribute to that initial appearance.
Treatment generally follows a treat, wait, and reassess approach. Providers should account for the gradual response rather than attempting to achieve the final correction during the first session.
Which Treatments Have U.S. FDA Approval?
FDA approval applies to specific products, treatment areas, patient groups, and preparation protocols. Providers should consult current manufacturer labeling when planning treatment.
| Treatment target | Radiesse / Radiesse (+) | Sculptra |
| Facial wrinkles and folds | Both have indications for moderate to severe facial wrinkles and folds, such as nasolabial folds | Shallow to deep nasolabial fold contour deficiencies and other facial wrinkles in immune-competent patients |
| Jawline contour | Radiesse (+): moderate to severe loss of jawline contour in adults over 21 | No specific U.S. jawline-contour indication |
| Back-of-hand volume loss | Radiesse has a dedicated hand-augmentation indication | No U.S. hand-augmentation indication |
| Décolleté wrinkles | Radiesse diluted 1:2 with 0.9% sterile saline in patients 22 and older | No U.S. décolleté indication |
| Fine lines and wrinkles in the cheeks | No equivalent dedicated cheek fine-line indication; general facial-wrinkle labeling remains separate | Specific indication in immune-competent patients |
The FDA approved Sculptra’s expanded indication for fine lines and wrinkles in the cheek region in April 2023.
The FDA expanded Radiesse’s indication to include moderate to severe décolleté wrinkles in patients 22 and older in March 2026. The approved treatment uses a specific 1:2 dilution protocol.
Does Sculptra Last Longer Than Radiesse?
Sculptra is commonly described as providing results for up to two years. Radiesse duration varies according to the indication, treatment area, treatment course, and outcome measured, and Merz currently states that Radiesse results may last up to two years.
These figures should not be interpreted as a direct head-to-head comparison.
FDA educational material has historically described CaHA filler effects as lasting approximately 18 months and PLLA effects as lasting up to two years. Different estimates can reflect different clinical evidence, indications, endpoints, and follow-up periods.
Published Radiesse research has also documented persistent improvement beyond shorter general duration estimates in certain treatment settings. For example, a long-term nasolabial-fold study reported persistent improvement in some treated folds at least 30 months after the last treatment.
That does not mean every patient will maintain full correction for that length of time.
When discussing longevity with patients, providers should match the evidence to the proposed treatment area and protocol rather than comparing the longest published endpoint for each product.
How Preparation and Follow-Up Differ
Sculptra requires reconstitution, while Radiesse preparation depends on the intended treatment and indication. Neither product guarantees a single-visit treatment course.
Sculptra Requires Reconstitution
Sculptra is supplied as a freeze-dried product and requires reconstitution with sterile water for injection.
Current U.S. labeling includes different preparation pathways depending on the applicable indication, including 5 mL and 8 mL pathways. Providers should follow current product labeling and indication-specific instructions rather than applying one preparation method universally.
Sterile water is the specified reconstitution fluid and should not be treated as interchangeable with saline. Current labeling also means that overnight hydration is not universally required for every approved preparation pathway.
Preparation includes achieving a uniform suspension and following the applicable handling and use limits.
Radiesse May Also Require a Treatment Series
Structural Radiesse can produce visible correction during the first appointment, but additional treatment may still be appropriate depending on the patient and indication.
Treatment schedules also vary by approved use. For décolleté wrinkles, the supporting clinical protocol used three treatment sessions at six-week intervals, with optional later retreatment.
Sculptra’s aesthetic labeling allows up to four sequential treatment sessions with reassessment between treatments.
Certain indications also require product-specific training. Providers should follow current labeling and manufacturer training requirements for the treatment they plan to perform.
Storage Is Not a Generic Cold-Chain Rule
Radiesse labeling specifies controlled room-temperature storage between 15°C and 32°C.
Unopened Sculptra can be stored at room temperature up to 30°C. Refrigeration is not required for unopened product, and freezing is prohibited.
Once Sculptra has been reconstituted, providers should follow the applicable instructions for handling and use. Practices should distinguish between storage requirements for unopened inventory and handling requirements for prepared product.
What Safety Factors Change the Choice?
Both products carry injection-related risks. Neither should be selected based on a blanket claim that one is universally safer than the other.
Dissolution and Delayed Complications
Hyaluronidase does not dissolve CaHA or PLLA particles the way it can dissolve hyaluronic acid filler. Natural biodegradation over time is different from having an immediate enzymatic reversal option.
Both products can be associated with nodules, inflammatory reactions, and other delayed complications. Rates from separate clinical studies should not be used to create a simple safety ranking because studies can differ in treatment area, technique, patient population, and follow-up.
Complication planning should therefore be considered alongside product selection. Practices need protocols for both immediate injection-related complications and delayed reactions.
Contraindications and Patient History
Radiesse lists bleeding disorders among its contraindications.
Sculptra is contraindicated in patients with a history of, or susceptibility to, keloid formation or hypertrophic scarring. Radiesse’s safety in patients susceptible to keloids or hypertrophic scars has not been studied, so simply switching products does not eliminate the need for careful patient assessment.
Severe allergies and hypersensitivity to product components also matter for both products. Lidocaine allergy requires additional consideration when using Radiesse (+) or when lidocaine is added to Sculptra under applicable instructions.
Radiesse’s safety and effectiveness in the lips and around the eyes have not been established. Sculptra safety information also warns against injection into the lip vermilion and periorbital area.
Neither product has established safety during pregnancy or breastfeeding.
Vascular Events and Documentation
Unintended injection into a blood vessel can cause serious complications, including tissue necrosis, vision abnormalities or vision loss, and stroke.
Practices need clinicians who can recognize signs of vascular compromise and activate an appropriate urgent-response pathway.
CaHA is radiopaque, meaning Radiesse may appear on CT scans and X-rays. Treatment records should document the product and treatment location, and patients should be advised to disclose prior Radiesse treatment when relevant to other clinicians or radiologists.
Radiesse or Sculptra: Which Should a Practice Stock?
Stocking decisions should follow recurring clinical indications, patient demand, applicable labeling, and the team’s competence with each product and protocol.
The treatment target should come first. Acquisition cost and inventory considerations can then support the clinical decision.
| Recurring clinical need | Product to evaluate first | Reason |
| Moderate to severe loss of jawline contour | Radiesse (+) | Specific U.S. jawline indication |
| Back-of-hand volume loss | Radiesse | Dedicated hand-augmentation indication |
| Fine lines and wrinkles in the cheeks | Sculptra | Specific cheek-wrinkle indication |
| Décolleté wrinkles | Radiesse under its approved diluted protocol | Area-specific indication with required protocol |
| Appropriate facial folds with a goal of immediate correction | Structural Radiesse | Initial filling from the gel carrier |
| Appropriate facial wrinkles with a goal of gradual correction | Sculptra | Staged collagen response |
| Patient requires a readily dissolvable filler option | Neither | CaHA and PLLA do not offer HA-style enzymatic dissolution |
Patient demand alone does not establish clinical suitability.
If both products address recurring and appropriate treatment needs within a practice, carrying both may make sense. However, stocking both products does not mean they are interchangeable or that using them together is appropriate for every patient.
Compare Cost Per Treatment Course, Not Per Syringe
Purchase price alone does not show the full cost of a Radiesse or Sculptra treatment plan.
For a useful biostimulator comparison, practices should evaluate the amount of product expected across the planned treatment course as well as preparation, clinical appointment time, consumables, follow-up visits, and expected waste.
A basic framework is:
Planned course cost = product units × acquisition cost + preparation + consumables + clinical time + planned follow-up
Sculptra commonly involves staged treatment and reconstitution, while Radiesse treatment planning varies by indication and patient need.
Neither fewer appointments nor a lower per-unit acquisition price automatically makes one treatment less expensive overall. Practices should evaluate costs in the context of the intended clinical outcome and complete treatment course.
What Makes Product Sourcing Verifiable?
Verifiable sourcing connects the manufacturer, the supply channel, and the specific product received by the practice.
When evaluating injectable products, practices should confirm the exact U.S.-market product, applicable labeling, expiration date, lot number, and package integrity. A familiar brand name alone does not establish that an imported or differently labeled presentation has U.S. approval.
Manufacturer confirmation of the supply channel provides stronger verification than relying only on a seller’s authenticity claim.
Practices should also maintain acquisition records that make individual products traceable if a recall, safety notice, or inventory issue occurs.
Ordering Radiesse for Your Practice
Licensed medical practices can order Radiesse through DeWitt Pharma.
DeWitt Pharma is a Dallas-based, family-owned medical supplier serving licensed professionals nationwide. Professional credentials are verified as part of the ordering process, helping practices purchase professional-use products through a streamlined online ordering system.
Practices should confirm the exact Radiesse product and presentation needed for their intended treatment before ordering and follow current manufacturer labeling, training requirements, and applicable clinical protocols.
Final Thoughts
Radiesse and Sculptra serve different clinical goals. Radiesse offers immediate structural correction with specific indications for the hands, jawline, and décolleté, while Sculptra provides gradual correction through collagen stimulation.
The right choice depends on the treatment area, patient needs, FDA labeling, and provider training. Practices considering Radiesse can explore wholesale Radiesse for licensed medical practices through DeWitt Pharma.
Looking to add other products and medical supplies? Visit DeWitt Pharma’s full product page.
Frequently Asked Questions
What is the main difference between Radiesse and Sculptra?
The main difference is how the products create correction. Structural Radiesse contains CaHA microspheres in a gel carrier and can provide immediate filling while supporting a later collagen response. Sculptra contains PLLA particles and produces correction more gradually through a collagen response. Sculptra also requires reconstitution before use.
Which lasts longer, Radiesse or Sculptra?
Sculptra is commonly described as providing results for up to two years, while Radiesse duration varies by indication and treatment area, with Merz also stating that results may last up to two years. These estimates come from different evidence and should not be interpreted as a direct head-to-head longevity comparison.
Is Radiesse or Sculptra better for immediate results?
Structural Radiesse is generally the more relevant product to evaluate when immediate filling is an appropriate treatment objective because its gel carrier contributes to initial correction. Sculptra’s lasting correction develops gradually, and the fullness seen immediately after treatment is partly related to reconstitution fluid and swelling. Product selection still depends on the treatment area, patient anatomy, applicable labeling, and clinical judgment.
Which FDA-approved treatment areas differ between Radiesse and Sculptra?
Radiesse has a dedicated indication for hand augmentation, while Radiesse (+) has an indication for moderate to severe loss of jawline contour in adults over 21. Radiesse also has an approved diluted protocol for moderate to severe décolleté wrinkles in patients 22 and older. Sculptra has a specific indication for fine lines and wrinkles in the cheek region in immune-competent patients. Providers should consult current U.S. labeling for complete indication and patient criteria.
Can Radiesse or Sculptra be dissolved?
Neither product offers the same enzymatic reversal available for hyaluronic acid fillers. Hyaluronidase does not dissolve CaHA or PLLA particles the way it dissolves hyaluronic acid. Their eventual biodegradation should not be confused with having an immediate dissolution option.
Can a practice stock both Radiesse and Sculptra?
Yes. A practice may stock both when each product addresses recurring and appropriate clinical needs and clinicians are trained to follow the relevant protocols. Carrying both does not make the products interchangeable or mean that combining them is appropriate for every patient.
Where can licensed clinics order Radiesse?
Licensed medical practices can order Radiesse through DeWitt Pharma. Practices should verify the exact product and presentation needed, maintain appropriate acquisition records, and follow current manufacturer labeling and training requirements. DeWitt Pharma verifies professional credentials and provides nationwide fulfillment for eligible medical practices.
